Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good ...
May 2, 2016 ... REGRANEX Gel contains becaplermin, a recombinant human platelet-derived growth factor for topical administration. Becaplermin is produced ...
Becaplermin Topical: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Easy to read patient leaflet for becaplermin. Includes indications, proper use, special instructions, precautions, and possible side effects.
Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, ...
Becaplermin (Regranex) is a drug prescribed to people with diabetes to help heal diabetic ulcers of the lower limbs. Some serious side effects may occur.
Jul 15, 2008 ... Becaplermin (Regranex) topical gel is labeled for adjunctive treatment of stage III and IV diabetic neuropathic ulcers of the lower extremities.
Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients ...
Local toxicity studies in humans were negative (repeated becaplermin gel application under occlusion to intact or abraded skin, dermal sensitization tests).
Medscape - Indication-specific dosing for Regranex Gel (becaplermin), frequency -based adverse effects, comprehensive interactions, contraindications, ...